TECX Price / Book | TECTONIC THERAPEUTIC, INC.

Tectonic Therapeutic, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

Tectonic Therapeutic, Inc. price/book ratio for the quarter ending 2026-06-30 was 2.94, a 124.97% increase year-over-year.
Tectonic Therapeutic, Inc. price/book ratio for the quarter ending 2026-03-31 was 2.53, a 130.49% increase year-over-year.
Tectonic Therapeutic, Inc. price/book ratio for the quarter ending 2025-12-31 was 1.55, a 68.12% decline year-over-year.
Tectonic Therapeutic, Inc. price/book ratio for the quarter ending 2025-09-30 was 1.1, a 63.12% decline year-over-year.
Tectonic Therapeutic, Inc. price/book ratio for fiscal 2026 was 2.94.
Tectonic Therapeutic, Inc. price/book ratio for fiscal 2025 was 1.55, a 68.12% decline from fiscal 2024.
Tectonic Therapeutic, Inc. price/book ratio for fiscal 2024 was 4.87, a change of 5.14 from fiscal 2023.
Tectonic Therapeutic, Inc. price/book ratio for fiscal 2023 was -0.27, a change of 7.92 from fiscal 2022.

Available history: 2018-06-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	2.94	$659M	$223.85M
2026-03-31	2.53	$583.37M	$230.42M
2025-12-31	1.55	$390.41M	$251.33M
2025-09-30	1.1	$293.14M	$267.53M
2025-06-30	1.31	$371.34M	$283.77M
2025-03-31	1.1	$330.67M	$301.04M
2024-12-31	4.87	$685.92M	$140.78M
2024-09-30	2.97	$446.76M	$150.36M
2024-06-30	1.46	$242.67M	$166.37M
2024-03-31	-6.92	$689.39M	-$99.57M
2023-12-31	-0.27	$22.97M	-$84.64M
2023-09-30	-10.32	$823.43M	-$79.78M
2023-06-30	-7.22	$505.11M	-$70M
2023-03-31	-8.84	$529.06M	-$59.82M
2022-12-31	-8.2	$374.16M	-$45.65M
2022-09-30	3.43	$336.18M	$98.09M
2022-06-30	4.08	$482.4M	$118.34M
2022-03-31	4.83	$692.14M	$143.16M
2021-12-31	11.9	$2.02B	$169.48M
2021-09-30	15.09	$2.92B	$193.57M
2021-06-30	21.06	$4.65B	$220.99M
2021-03-31	27.3	$6.36B	$232.93M
2020-12-31	28.71	$7.3B	$254.34M
2020-09-30	27.4	$5.69B	$207.87M
2020-06-30	31.82	$7.63B	$239.79M
2020-03-31	26.21	$6.72B	$256.53M
2019-12-31	41.09	$7.64B	$186.01M
2019-09-30	25.9	$5.36B	$206.76M
2019-06-30	50.75	$4.7B	$92.63M
2019-03-31	59.35	$6.34B	$106.79M
2018-12-31	38.93	$4.76B	$122.18M
2018-09-30	107.86	$14.79B	$137.11M
2018-06-30	54.81	$8.13B	$148.32M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	2.94	$659M	$223.85M
2025-12-31	1.55	$390.41M	$251.33M
2024-12-31	4.87	$685.92M	$140.78M
2023-12-31	-0.27	$22.97M	-$84.64M
2022-12-31	-8.2	$374.16M	-$45.65M
2021-12-31	11.9	$2.02B	$169.48M
2020-12-31	28.71	$7.3B	$254.34M
2019-12-31	41.09	$7.64B	$186.01M
2018-12-31	38.93	$4.76B	$122.18M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
REGENXBIO Inc. (RGNX)	United States	$0.477B	-3.30
Entera Bio Ltd. (ENTX)		$0.485B
Eikon Therapeutics, Inc. (EIKN)	United States	$0.446B
Kyverna Therapeutics, Inc. (KYTX)	United States	$0.434B	-3.60
Autolus Therapeutics plc (AUTL)		$0.506B	-1.52
Editas Medicine, Inc. (EDIT)	United States	$0.424B	-4.29
Scribe Therapeutics, Inc. (SCTX)	United States	$0.410B
Zura Bio Ltd (ZURA)		$0.398B	-6.56
Surrozen, Inc./DE (SRZN)	United States	$0.395B
AGENUS INC (AGEN)	United States	$0.383B	1.41